Cubist Systematic Strategies, LLC Mirum Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 296,887 shares of MIRM stock, worth $15.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

296,887

Previous 83,969 253.57%

Holding current value

$15.9 Million

Previous $3.47 Million 285.2%

% of portfolio

0.09%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$41.32 - $53.16 $8.8 Million - $11.3 Million	212,918 Added 253.57%	296,887 $13.4 Million
Q4 2024 Feb 14, 2025	SELL	$37.85 - $46.65 $560,066 - $690,280	-14,797 Reduced 14.98%	83,969 $3.47 Million
Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $3.33 Million - $4.42 Million	98,766 New	98,766 $3.85 Million
Q1 2024 May 15, 2024	SELL	$24.92 - $30.02 $1.17 Million - $1.42 Million	-47,150 Reduced 86.75%	7,199 $180,000
Q4 2023 Feb 14, 2024	SELL	$27.14 - $34.93 $1.19 Million - $1.53 Million	-43,765 Reduced 44.61%	54,349 $1.6 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $2.32 Million - $3.09 Million	94,104 Added 2346.73%	98,114 $3.1 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $46,455 - $59,457	1,976 Added 97.15%	4,010 $103,000
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $39,032 - $49,019	2,034 New	2,034 $48,000
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $489,345 - $730,565	26,566 Added 168.32%	42,349 $824,000
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $203,577 - $314,296	13,134 Added 495.81%	15,783 $348,000
Q4 2021 Feb 14, 2022	SELL	$13.05 - $19.35 $33,812 - $50,135	-2,591 Reduced 49.45%	2,649 $42,000
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $50,526 - $73,091	3,622 Added 223.86%	5,240 $104,000
Q2 2021 Aug 16, 2021	SELL	$15.84 - $20.6 $105,193 - $136,804	-6,641 Reduced 80.41%	1,618 $28,000
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $23,359 - $31,433	-1,434 Reduced 14.79%	8,259 $164,000
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $152,664 - $246,686	9,693 New	9,693 $169,000
Q3 2020 Nov 16, 2020	SELL	$18.4 - $26.59 $1,839 - $2,659	-100 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.51 - $20.97 $1,151 - $2,097	100 New	100 $2,000

Others Institutions Holding MIRM

# of Institutions

230

Shares Held

55.9M

Call Options Held

27.4K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.96B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Mirum Pharmaceuticals, Inc. Transaction History